LYNN VINAY: Open Payments
NPI 1568914646 · VENICE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,419 in 60 payments from 17 companies in 2025. Trend: 2023 $36 · 2024 $0 · 2025 $1,419
Food & beverage: $1,419
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $206 |
| Lundbeck LLC | 7 | $175 |
| TMS NeuroHealth Centers Inc. | 3 | $134 |
| ABBVIE INC. | 4 | $119 |
| Vanda Pharmaceuticals Inc. | 4 | $110 |
| Noven Therapeutics, LLC | 6 | $104 |
| Alkermes, Inc. | 4 | $95 |
| Axsome Therapeutics, Inc. | 3 | $79 |
| Tris Pharma Inc | 4 | $78 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $54 |
Products named: CAPLYTA, REXULTI, TMS NeuroHealth Centers Inc., VRAYLAR, FANAPT, Xelstrym, ARISTADA, Auvelity.
Industry payments across FL — which companies pay providers there.
